Calls for Research Grants
1. Research Mobility Fellowships - Call will open October 01, 2020
As part of its educational activities, EJP RD runs a Research Mobility Fellowship Programme dedicated to young researchers in the European Reference Networks (ERNs). PhD students and medical doctors in training from ERN member and Affiliated Partner institutions can apply for funding of short-term (1 to 3 months) training visits at another ERN center outside their country of residence. The aim of the programme is to foster the acquisition of skills and knowledge relevant to rare disease research. Both clinical and translational research projects are eligible for funding.
The first round of applications has been concluded successfully in July 2020. Out of 16 applications received, the Scientific Evaluation Committee selected six outstanding applications by fellows from Belgium, Denmark, The Netherlands, Slovenia, Spain and the UK. The exchange visits will involve research units from the following ERNs: ERN-RND, EURO-NMD, ERKNet, eUROGEN, ERNICA and ERN-Eye.
All proposals were evaluated of the Scientific Evaluation Committee (SEC) composed of three WP17 leaders, three independent external scientific experts and one representative of the EJP RD office.
For the next programme call, EJP RD encourages junior physicians and PhD students to apply to this prestigious programme and add this exciting and unique experience to their professional education path and background.
2. Research Training Workshops - Call open until September 28, 2020
This program will fund the organization of two-day research training workshops. The workshops can be proposed by the ERN and EJP-RD members and will be open exclusively to ERN researchers, who will be invited upon application and will receive full coverage of their travel and accommodation cost. The workshops should cover innovative research themes including novel laboratory or diagnostic or therapeutic methodologies relevant to rare diseases. Interdisciplinary and inter-ERN initiatives will be welcome.